<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Health and Population Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2C0EDC2F-3E48-4DC7-911D-5565EF88CAD5"><gtr:id>2C0EDC2F-3E48-4DC7-911D-5565EF88CAD5</gtr:id><gtr:firstName>Frederick</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Hobbs</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E7EF463D-D71E-41ED-BEBE-DE8BEEC563EC"><gtr:id>E7EF463D-D71E-41ED-BEBE-DE8BEEC563EC</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Fitzmaurice</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4BE1723F-7BD8-47FE-91AE-4486386AC5DF"><gtr:id>4BE1723F-7BD8-47FE-91AE-4486386AC5DF</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Raftery</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EB6D3890-A7F3-4E1A-8A14-C352CB9CE9AE"><gtr:id>EB6D3890-A7F3-4E1A-8A14-C352CB9CE9AE</gtr:id><gtr:firstName>ET</gtr:firstName><gtr:surname>Murray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E67584E-84C6-482A-93E9-7DF1EE718117"><gtr:id>3E67584E-84C6-482A-93E9-7DF1EE718117</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Mant</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4D0641E0-82A5-4A44-BB37-91907D94F0B6"><gtr:id>4D0641E0-82A5-4A44-BB37-91907D94F0B6</gtr:id><gtr:firstName>Gregory</gtr:firstName><gtr:otherNames>Yoke</gtr:otherNames><gtr:surname>Lip</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9900264"><gtr:id>20D2BEDB-6288-4055-9F5A-A62E3DEC0DC6</gtr:id><gtr:title>An RCT of warfarin versus aspirin for atrial fibrillation in an elderly (aged over 74) primary care population</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9900264</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>943679</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Public Health and Primary Care</gtr:department><gtr:description>Primary Care Stroke Prevention Programme</gtr:description><gtr:id>39C2CD4B-0151-40F4-BAC8-B68C582797A0</gtr:id><gtr:impact>Fletcher K, Mant J, McManus R, Campbell S, Betts J, Taylor C, Virdee S, Jowett S, Martin U, Greenfield S, Ford G, Freemantle N, Hobbs FD. Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care. BMC Cardiovasc Disord. 2010; 10: 37
Fletcher K, Mant J, McManus R, Campbell S, Betts J, Taylor C, Virdee S, Jowett S, Martin U, Greenfield S, Ford G, Freemantle N, Hobbs FD. Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care. BMC Cardiovasc Disord. 2010 Aug 9;10:37.</gtr:impact><gtr:partnerContribution>Design and delivery</gtr:partnerContribution><gtr:piContribution>Ongoing links with Prof Jonathan Mant, University of Cambridge over new trials and studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Society Guideline Working Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE3F2928-462F-4196-8981-582634930AB8</gtr:id><gtr:impact>Review of SPAF guidelines

NICE recommended changes and new LES policy for AF management in primary care.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR Stroke Prevention Programme RP-PG-0606-1153</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>DBDF38FB-23DA-458C-9B8E-CCB9C41C7BE0</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B2D93051-C6A6-4A71-9F3E-8E5614A6877B</gtr:id><gtr:impact>hjopefully informed clinical practice</gtr:impact><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>American and European AF Guidelines</gtr:guidelineTitle><gtr:id>68B9245E-D079-4163-BCE8-AA6909B6EA28</gtr:id><gtr:impact>Changed guidelines</gtr:impact><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7A26F048-6D17-4A6E-AC1A-865B58C28832"><gtr:id>7A26F048-6D17-4A6E-AC1A-865B58C28832</gtr:id><gtr:title>Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study.</gtr:title><gtr:parentPublicationTitle>Family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cd03724019b172c9a773c91621be1f65"><gtr:id>cd03724019b172c9a773c91621be1f65</gtr:id><gtr:otherNames>Fletcher K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0263-2136</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E22F73C-28FC-41A7-94A5-27F78F1AB226"><gtr:id>8E22F73C-28FC-41A7-94A5-27F78F1AB226</gtr:id><gtr:title>Response to letter regarding article, &amp;quot;warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3bf1c628f1c68d5d7df904021048cfa7"><gtr:id>3bf1c628f1c68d5d7df904021048cfa7</gtr:id><gtr:otherNames>Mavaddat N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14BF68FA-5DFF-4124-B4A2-CD5A688A1A71"><gtr:id>14BF68FA-5DFF-4124-B4A2-CD5A688A1A71</gtr:id><gtr:title>Incidence of venous thromboembolism in care homes: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>The British journal of general practice : the journal of the Royal College of General Practitioners</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c634f1a058ae1781a57166ec2cfceead"><gtr:id>c634f1a058ae1781a57166ec2cfceead</gtr:id><gtr:otherNames>Apenteng PN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-1643</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32186CDC-EF33-4AE5-89B6-6FCA41FD3FF9"><gtr:id>32186CDC-EF33-4AE5-89B6-6FCA41FD3FF9</gtr:id><gtr:title>Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08447c6f05f2b074862944fa820ae14a"><gtr:id>08447c6f05f2b074862944fa820ae14a</gtr:id><gtr:otherNames>Hobbs FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D9A82A5-10B0-4A76-BC4C-069DE95C3BEC"><gtr:id>5D9A82A5-10B0-4A76-BC4C-069DE95C3BEC</gtr:id><gtr:title>Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation.</gtr:title><gtr:parentPublicationTitle>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4590b1fceb1d40196c4b42c6e34c322e"><gtr:id>4590b1fceb1d40196c4b42c6e34c322e</gtr:id><gtr:otherNames>Camm AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1099-5129</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9287711-4F5C-4E47-B144-E6A24CD17CE9"><gtr:id>A9287711-4F5C-4E47-B144-E6A24CD17CE9</gtr:id><gtr:title>Ethnic-Specific Normative Reference Values for Echocardiographic LA&amp;nbsp;and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study.</gtr:title><gtr:parentPublicationTitle>JACC. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27cefb1ef84b30f4725a890348617753"><gtr:id>27cefb1ef84b30f4725a890348617753</gtr:id><gtr:otherNames>Echocardiographic Normal Ranges Meta-Analysis of the Left Heart Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1876-7591</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/73CA55D4-A493-411F-A4F6-7BFB52D66507"><gtr:id>73CA55D4-A493-411F-A4F6-7BFB52D66507</gtr:id><gtr:title>Stroke detection and prevention in atrial fibrillation.</gtr:title><gtr:parentPublicationTitle>The British journal of general practice : the journal of the Royal College of General Practitioners</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08447c6f05f2b074862944fa820ae14a"><gtr:id>08447c6f05f2b074862944fa820ae14a</gtr:id><gtr:otherNames>Hobbs FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-1643</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C52C5B4-70BD-472D-B1A6-90B3635F4D02"><gtr:id>0C52C5B4-70BD-472D-B1A6-90B3635F4D02</gtr:id><gtr:title>Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0dd6ecccfd6140f5b280451254a3a945"><gtr:id>0dd6ecccfd6140f5b280451254a3a945</gtr:id><gtr:otherNames>van Walraven C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/08ECB61B-78DE-4331-BB38-540C2C1D7A73"><gtr:id>08ECB61B-78DE-4331-BB38-540C2C1D7A73</gtr:id><gtr:title>Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/58f10f9b16b3ddbee79ca56f4d01cf63"><gtr:id>58f10f9b16b3ddbee79ca56f4d01cf63</gtr:id><gtr:otherNames>Kearley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E2D0399-3BA5-42BA-891F-871432048608"><gtr:id>0E2D0399-3BA5-42BA-891F-871432048608</gtr:id><gtr:title>Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c7fa02a583838932b969061b1434dcd"><gtr:id>2c7fa02a583838932b969061b1434dcd</gtr:id><gtr:otherNames>Mant J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8F84A1B-5563-4B3F-88C2-F5F4B814029A"><gtr:id>A8F84A1B-5563-4B3F-88C2-F5F4B814029A</gtr:id><gtr:title>Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study.</gtr:title><gtr:parentPublicationTitle>Family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/585116518a712c00e2062ec4e003c655"><gtr:id>585116518a712c00e2062ec4e003c655</gtr:id><gtr:otherNames>Fitzmaurice DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0263-2136</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97478C2C-F0EB-4D6A-B7AA-193723149048"><gtr:id>97478C2C-F0EB-4D6A-B7AA-193723149048</gtr:id><gtr:title>A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.</gtr:title><gtr:parentPublicationTitle>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/155789e4c0513a9331cc5984e8f249cf"><gtr:id>155789e4c0513a9331cc5984e8f249cf</gtr:id><gtr:otherNames>Roalfe AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1099-5129</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C130793A-18C7-40D0-92F6-338330CE0452"><gtr:id>C130793A-18C7-40D0-92F6-338330CE0452</gtr:id><gtr:title>Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08447c6f05f2b074862944fa820ae14a"><gtr:id>08447c6f05f2b074862944fa820ae14a</gtr:id><gtr:otherNames>Hobbs FD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0CE63580-73E0-4C29-AA21-172FFE69FC05"><gtr:id>0CE63580-73E0-4C29-AA21-172FFE69FC05</gtr:id><gtr:title>A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c31e58980187e63ec97be1b99ee1077b"><gtr:id>c31e58980187e63ec97be1b99ee1077b</gtr:id><gtr:otherNames>Hurley V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30497D39-8B9E-4236-AB0F-8C45ECDE3FEB"><gtr:id>30497D39-8B9E-4236-AB0F-8C45ECDE3FEB</gtr:id><gtr:title>Research into practice: management of atrial fibrillation in general practice.</gtr:title><gtr:parentPublicationTitle>The British journal of general practice : the journal of the Royal College of General Practitioners</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/585116518a712c00e2062ec4e003c655"><gtr:id>585116518a712c00e2062ec4e003c655</gtr:id><gtr:otherNames>Fitzmaurice DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-1643</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26E0C1E5-C689-4140-963A-F43D45EC1257"><gtr:id>26E0C1E5-C689-4140-963A-F43D45EC1257</gtr:id><gtr:title>An analysis of factors that predict patient consent to take part in a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cd03724019b172c9a773c91621be1f65"><gtr:id>cd03724019b172c9a773c91621be1f65</gtr:id><gtr:otherNames>Fletcher K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0263-2136</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9900264</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>